TY - JOUR
T1 - Harmonizing factor assay-related testing performed in a large laboratory network
AU - Favaloro, Emmanuel J
AU - Mohammed, Soma
AU - Vong, Ronny
AU - Chapman, Kent
AU - Swanepoel, Priscilla
AU - Kershaw, Geoffrey
AU - Cai, Nancy
AU - Just, Sarah
AU - Connelly, Lynne
AU - Brighton, Timothy
AU - Pasalic, Leonardo
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/10/1
Y1 - 2022/10/1
N2 - Coagulation factor testing is commonly performed within haemostasis laboratories, either to assess for bleeding disorders, such as haemophilia, or to investigate unexplained prolongation in routine coagulation assays. The aim of this evaluation was to harmonize procedures and normal reference ranges (NRRs) for investigation of coagulation factors on the ACL TOP 50 family of instruments in a large laboratory network. We employed comparative evaluations using newly installed ACL TOPs 550 and 750 and HemosIL reagents vs. existing 'reference' instrumentation and reagents, predominantly Stago and Siemens, as well as assessment of factor sensitivity in routine coagulation assays, prothrombin time (PT) and activated partial thromboplastin time (APTT). Also, establishment of coagulation factor NRRs using normal plasma samples. HemosIL factor assays showed good comparability with the existing reference methods (R > 0.9). Factor sensitivity for PT and APTT assays were acceptable at around 30 U/dl. NRRs were established and harmonized across the laboratory network. This evaluation of factor testing on ACL TOP 50 Family instruments identified overall acceptable performance using Werfen reagents and enabled harmonization of coagulation factor testing in our large network.
AB - Coagulation factor testing is commonly performed within haemostasis laboratories, either to assess for bleeding disorders, such as haemophilia, or to investigate unexplained prolongation in routine coagulation assays. The aim of this evaluation was to harmonize procedures and normal reference ranges (NRRs) for investigation of coagulation factors on the ACL TOP 50 family of instruments in a large laboratory network. We employed comparative evaluations using newly installed ACL TOPs 550 and 750 and HemosIL reagents vs. existing 'reference' instrumentation and reagents, predominantly Stago and Siemens, as well as assessment of factor sensitivity in routine coagulation assays, prothrombin time (PT) and activated partial thromboplastin time (APTT). Also, establishment of coagulation factor NRRs using normal plasma samples. HemosIL factor assays showed good comparability with the existing reference methods (R > 0.9). Factor sensitivity for PT and APTT assays were acceptable at around 30 U/dl. NRRs were established and harmonized across the laboratory network. This evaluation of factor testing on ACL TOP 50 Family instruments identified overall acceptable performance using Werfen reagents and enabled harmonization of coagulation factor testing in our large network.
KW - activated partial thromboplastin time
KW - laboratory testing
KW - one-stage coagulation factor assays
KW - prothrombin time
KW - verification
U2 - 10.1097/MBC.0000000000001155
DO - 10.1097/MBC.0000000000001155
M3 - Article
C2 - 35867944
SN - 0957-5235
VL - 33
SP - 402
EP - 411
JO - Blood Coagulation and Fibrinolysis: international journal in haemostasis and thrombosis
JF - Blood Coagulation and Fibrinolysis: international journal in haemostasis and thrombosis
IS - 7
ER -